Global /India /Healthcare /Drug Manufacturers - General /526075

Rekvina Laboratories Ltd.

526075 (VINRKLB)

• BSE: 526075 • Delayed

44.18INR -2%

0.4679 USD

As of 20 June 2026, Rekvina Laboratories Ltd. has a market cap of $2.82M USD, ranking #46378 globally and #4329 in India. It ranks #4114 in the Healthcare sector, and #1313 in the Drug Manufacturers - General industry.

Global Rank

46378

Country Rank

4329

Sector Rank

4114

Industry Rank

1313

Key Stats

Market Cap

$2.82MUSD

266.32M INR

Enterprise Value

$2.91MUSD

274.42M INR

Revenue (TTM)

$57.4KUSD

5.42M INR

Net Income (TTM)

-$25.11KUSD

-2.37M INR

Profit Margin

-44%

PS Ratio

49.2

PB Ratio

-35.4

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Amit Shah open_in_new

Employees

Founded

1988

Website

rekvinalaboratories.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2%	2.5%	27%	312%	732%	455%	732%	732%	891%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	526075 (VINRKLB) Rekvina Laboratories Ltd ISIN: INE092O01028 TV: TradingView: BSE: VINRKLB SA: Stock Analysis: BOM: 526075 YF: Yahoo Finance: 526075.BO GF: Google Finance: BOM: 526075 BA: Barron's: 526075 MS: Morningstar: XBOM: 526075	44.18 INR	TV: TradingView: BSE: VINRKLB SA: Stock Analysis: BOM: 526075 YF: Yahoo Finance: 526075.BO GF: Google Finance: BOM: 526075 BA: Barron's: 526075 MS: Morningstar: XBOM: 526075

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Rekvina Laboratories Ltd.

Rekvina Laboratories Limited engages in manufacturing and marketing pharmaceutical products in India. It offers pharmaceutical formulations. The company also provides contract research and manufacturing services. Rekvina Laboratories Limited was incorporated in 1988 and is based in Vadodara, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 2M%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 651K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 537K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 416K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 350K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 344K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 27M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 19M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 13M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 11M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 10M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 10M%	15.1	United States

chevron_leftBack